Skip to main content

Donate Today

Every gift, no matter the size, helps change children’s lives.

Karla V. Resendiz, PharmD, BCPPS, BCCCP

Karla Resendiz, PharmD, BCPPS, BCCCP

Karla V. Resendiz, PharmD, BCPPS, BCCCP

(She/Her)

Karla Resendiz, PharmD, BCPPS, BCCCP, is a residency preceptor with the Pharmacy Residency Program and a clinical pharmacy specialist in Pediatric Critical Care at Children's Hospital of Philadelphia.

Areas of expertise: Sedation, Nutrition support, Pediatric cardiopulmonary resuscitation

Locations: Main Building

About Karla V. Resendiz, PharmD, BCPPS, BCCCP

Titles

Clinical Pharmacy Specialist, Pediatric Critical Care

Pharmacy Residency Program Preceptor

Pharmacy Residency Program Research Committee Co-Chair

Certifications

Board Certified Critical Care Pharmacist (BCCCP)

Board Certified Pediatric Pharmacy Specialist (BCPPS)

Leadership and Memberships

Pediatric Pharmacy Association (PPA): Practice-based Research Networks Subcommittee Co-Chair

Society of Critical Care Medicine (SCCM): Item Writing Committee, ICU Liberation Committee

Research Interests

Sedation Nutrition Support Cardiopulmonary resuscitation

Education & training

Graduate Degree

Doctor of Pharmacy – University of Texas at Austin, Austin, TX 

Residency

Pharmacy Practice (PGY 1) – Children’s National Medical Center, Washington, DC
Pediatric Specialty (PGY 2) – Medical University of South Carolina, Charleston, SC

Team affiliations

View fewer team affiliations View all team affiliations

Publications

Publications

2024

Weber MD, Woods-Hill C, Resendiz K, et al. Safety and Efficacy of Ethanol for Catheter Salvage and Central Line-Associated Bloodstream Infection Prophylaxis in Polyurethane Catheters in the PICU. Pediatr Crit Care Med. 2024 May 1;25(5):e232-e238.

Jacobwitz M, Mulvihill C, Kaufman MC, Gonzalez AK, Resendiz K, et al. A Comparison of Ketamine and Midazolam as First-Line Anesthetic Infusions for Pediatric Status Epilepticus. Neurocrit Care. 2024 Jun;40(3):984-995.

2022

Resendiz K. Inhalation Lung Injuries. In: Lee BR, Ohler KH, eds. Pediatric Self-Assessment Program, 2022 Book 1. Critical Care. Lenexa, KS: American College of Clinical Pharmacy, 2022:7-24.

Jacobwitz M, Mulvihill C, Kaufman MC, Gonzalez AK, Resendiz K, et al. Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus. Neurology. 2022; 99(12):e1227-e1238.

2020

Blowey B, Resendiz K, Grachen A et al. Prevention is better than cure: The vital role of the clinical pharmacist in the pediatric intensive care unit to prevent medication errors. J Pediatr Crit Care 2020; 7(5):235

O’Neil ER; Schmees LR; Resendiz K et al. Inhaled Tranexamic Acid As a Novel Treatment for Pulmonary Hemorrhage in Critically Ill Pediatric Patients. Crit Care Explor 2020; 2(1):e0075

Resendiz K, Humlicek TJ, Moffett BS. Drugs. In Mery CM (ed), Texas Children’s Hospital Handbook of Congenital Heart Disease (pp.522-534). Houston, TX: Texas Children’s Hospital, 2020.

Jump back to top